Showing results (231-240 of 259) with videos related to

Sort By:
Pageof 26
Plos Genetics|February 9, 2022
Ribosomal DNA promoter recognition is determined in vivo by cooperation between UBTF1 and SL1 and is compromised in the UBTF-E210K neuroregression syndromeMichel G Tremblay, Dany S Sibai, Melissa Valère, et al.
Bulletin Du Cancer|September 2, 2000
[Standards, Options and Recommendations (SOR) for the surveillance and the prevention of cross infections in oncology. Fédération Nationale des Centres de Lutte Contre le Cancer]B Pottecher, R Herbrecht, M P Blanc-Vincent, et al.
Presse Medicale (Paris, France : 1983)|November 10, 2000
[Infection and cancer: general information and specific questions]M Viot, M P Blanc-Vincent, J Béal, et al.
Developmental Biology|April 25, 2006
Role of Sox2 in the development of the mouse neocortexMahmud Bani-Yaghoub, Roger G Tremblay, Joy X Lei, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1996
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcomeM Maziade, S Bouchard, N Gingras, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|November 5, 1997
Efficacy and safety of a new hydroxymethylglutaryl-coenzyme A reductase inhibitor, atorvastatin, in patients with combined hyperlipidemia: comparison with fenofibrateT C Ooi, T Heinonen, P Alaupovic, et al.
Gene Therapy|June 22, 2012
Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trialD Gaudet, J Méthot, S Déry, et al.
The British Journal of Psychiatry : the Journal of Mental Science|September 1, 1996
Long-term stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onsetM Maziade, N Gingras, C Rodrigue, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 2, 2005
A randomised trial of high-dose chemotherapy in the salvage treatment of patients failing first-line platinum chemotherapy for advanced germ cell tumoursJ-L Pico, G Rosti, A Kramar, et al.
Bone Marrow Transplantation|June 14, 2006
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphomaD Coso, C Sebban, O Boulat, et al.
Pageof 26